Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ASND Ascendis Pharma A/S	$162.00 +1.2%	$157.41	$111.09 ▼ $183.00	$9.88B	0.41	487,685 shs	212,034 shs
BRO Brown & Brown	$110.83 +0.4%	$115.55	$85.97 ▼ $125.68	$31.76B	0.87	1.49 million shs	1.21 million shs
GRI GRI Bio	$1.20 -4.0%	$2.40	$1.10 ▼ $86.19	$2.30M	-1.67	314,456 shs	255,863 shs
IZN InZinc Mining	C$0.02 -20.0%	C$0.02	C$0.02 ▼ C$0.04	C$2.47M	3.76	91,585 shs	5,000 shs

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ASND Ascendis Pharma A/S	0.00%	+2.79%	+0.97%	+6.28%	+23.53%
BRO Brown & Brown	0.00%	-0.82%	-5.92%	-0.74%	+21.58%
GRI GRI Bio	0.00%	-20.00%	-28.14%	+189.16%	-98.80%
IZN InZinc Mining	0.00%	-20.00%	0.00%	0.00%	-33.33%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ASND Ascendis Pharma A/S	3.3461 of 5 stars	4.5	3.0	0.0	0.0	2.8	1.7	0.6
BRO Brown & Brown	4.0637 of 5 stars	2.2	5.0	1.7	2.5	2.5	2.5	1.3
GRI GRI Bio	2.6751 of 5 stars	3.5	4.0	0.0	0.0	2.6	0.0	1.3
IZN InZinc Mining	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ASND Ascendis Pharma A/S	3.00	Buy	$216.07	33.37% Upside
BRO Brown & Brown	2.43	Hold	$116.85	5.43% Upside
GRI GRI Bio	3.00	Buy	$115.50	9,525.00% Upside
IZN InZinc Mining	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest IZN, BRO, GRI, and ASND Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/13/2025	BRO Brown & Brown	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$126.00 ➝ $119.00
5/12/2025	ASND Ascendis Pharma A/S	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$200.00 ➝ $200.00
5/5/2025	ASND Ascendis Pharma A/S	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$180.00 ➝ $250.00
5/5/2025	BRO Brown & Brown	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underperform ➝ Underperform	$102.00 ➝ $100.00
5/2/2025	ASND Ascendis Pharma A/S	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$205.00 ➝ $210.00
5/2/2025	ASND Ascendis Pharma A/S	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$200.00 ➝ $245.00
5/2/2025	ASND Ascendis Pharma A/S	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$181.00 ➝ $212.00
5/2/2025	ASND Ascendis Pharma A/S	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$260.00 ➝ $280.00
4/30/2025	BRO Brown & Brown	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$138.00 ➝ $130.00
4/16/2025	ASND Ascendis Pharma A/S	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$205.00
4/16/2025	BRO Brown & Brown	Edward Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy

(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ASND Ascendis Pharma A/S	$368.70M	26.79	N/A	N/A	($1.88) per share	-86.17
BRO Brown & Brown	$4.85B	6.55	$4.49 per share	24.67	$22.51 per share	4.92
GRI GRI Bio	N/A	N/A	N/A	N/A	$5.22 per share	N/A
IZN InZinc Mining	N/A	N/A	C$0.02 per share	1.20	C$0.02 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ASND Ascendis Pharma A/S	-$409.12M	-$6.28	N/A	675.00	N/A	-104.54%	N/A	-39.23%	N/A
BRO Brown & Brown	$993M	$3.59	32.03	24.41	2.93	20.68%	17.81%	6.69%	7/28/2025 (Estimated)
GRI GRI Bio	-$13.04M	-$11.56	N/A	N/A	N/A	N/A	-289.05%	-165.01%	8/12/2025 (Estimated)
IZN InZinc Mining	-C$1.28M	N/A	2.00	∞	N/A	N/A	-16.50%	-9.89%	N/A

Latest IZN, BRO, GRI, and ASND Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/15/2025	Q1 2025	GRI GRI Bio	-$4.08	-$5.80	-$1.72	-$5.80	N/A	N/A
5/1/2025	Q1 2025	ASND Ascendis Pharma A/S	-$1.56	-$1.66	-$0.10	-$1.66	$98.56 million	$123.97 million
4/28/2025	Q1 2025	BRO Brown & Brown	$1.30	$1.29	-$0.01	$1.15	$1.41 billion	$1.40 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ASND Ascendis Pharma A/S	N/A	N/A	N/A	N/A	N/A
BRO Brown & Brown	$0.60	0.54%	N/A	16.71%	N/A
GRI GRI Bio	$1.91	159.17%	N/A	N/A	N/A
IZN InZinc Mining	N/A	N/A	N/A	N/A	N/A

Latest IZN, BRO, GRI, and ASND Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/28/2025	BRO Brown & Brown	quarterly	$0.15	0.52%	5/12/2025	5/12/2025	5/21/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ASND Ascendis Pharma A/S	N/A	1.17	0.84
BRO Brown & Brown	0.56	1.79	1.79
GRI GRI Bio	N/A	3.10	3.10
IZN InZinc Mining	N/A	26.59	24.92

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ASND Ascendis Pharma A/S	N/A
BRO Brown & Brown	71.01%
GRI GRI Bio	33.95%
IZN InZinc Mining	3.24%

Insider Ownership

Company	Insider Ownership
ASND Ascendis Pharma A/S	40.00%
BRO Brown & Brown	17.02%
GRI GRI Bio	0.13%
IZN InZinc Mining	20.14%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ASND Ascendis Pharma A/S	640	60.97 million	36.41 million	Optionable
BRO Brown & Brown	15,200	286.61 million	237.27 million	Optionable
GRI GRI Bio	1	1.91 million	8.92 million	Not Optionable
IZN InZinc Mining	N/A	123.40 million	N/A	Not Optionable